Pneumococcal Conjugate Vaccines Reduces Incidence of Pneumonia for Children 2 Years and Under

Pneumococcal conjugate vaccines (PCV) reduced the incidence of pneumonia and improved levels of IgG antibodies in pediatric patients, according to results of a study published in Frontiers in Pediatrics. However, there is a lack of data on adverse events in children, so investigators stated that safety outcomes have to be explored more in future randomized controlled trials.¹

“Pneumococcal infections are the leading cause of childhood morbidity and mortality, especially in developing countries,” the study authors said.¹ “PCV, as an important component of the global childhood immunization program, has been widely recognized for its efficacy in…